Delving into the Latest Updates on Huangqi powder pellets with Synapse

Overview

Basic Info

Drug Type

Herbal medicine

Synonyms-

Target-

Mechanism-

Therapeutic Areas

Endocrinology and Metabolic DiseaseUrogenital Diseases

Active Indication

Diabetic Nephropathies

Inactive Indication-

Originator Organization-

Active Organization

Guangzhou Consun Pharmaceutical Research Co., Ltd.

Consun Pharmaceutical (Inner Mongolia) Co., Ltd.

Inactive Organization-

Drug Highest PhasePhase 2

First Approval Date-

Regulation-

Login to view timeline

To preliminarily evaluate the efficacy and safety of Huangqi Powder Micropills in the treatment of diabetic kidney disease (Qi deficiency syndrome), explore the advantageous dose of Huangqi Powder Micropills in the treatment of diabetic kidney disease, and provide support for the next step of clinical research design.

Start Date31 Jan 2021

Sponsor / Collaborator

Consun Pharmaceutical (Inner Mongolia) Co., Ltd.

[+1]

100 Clinical Results associated with Huangqi powder pellets

Login to view more data

100 Translational Medicine associated with Huangqi powder pellets

Login to view more data

100 Patents (Medical) associated with Huangqi powder pellets

Login to view more data

100 Deals associated with Huangqi powder pellets

Login to view more data

R&D Status

10 top R&D records.

Login

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Diabetic Nephropathies	Phase 2	CN	Consun Pharmaceutical (Inner Mongolia) Co., Ltd.	31 Jan 2021
Diabetic Nephropathies	Phase 2	CN	Guangzhou Consun Pharmaceutical Research Co., Ltd.	31 Jan 2021